Search Result "ipilimumab."
Ipilimumab Targeting CD28-CTLA-4 Axis: New Hope in the Treatment of Melanoma
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2012 Page: 61-66
Author(s): Marko Lens, Alessandro Testori, Pier Francesco Ferucci
Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3 Issue: 2 Year: 2008 Page: 105-113
Author(s): Marko Lens, Pier F. Ferrucci, Alessandro Testori
Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 8 Year: 2013 Page: 879-894
Author(s): Ana Burgeiro,Faustino Mollinedo,Paulo J. Oliveira
Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy
Journal: Current Cancer Therapy Reviews
Volume: 16 Issue: 1 Year: 2020 Page: 78-85
Author(s): Jason Liu,Cong Xu,Junjia Zhu,Jeffrey Sivik,Joseph J. Drabick,Heath B. Mackley
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 81-86
Author(s): Marlana Orloff, Ryan Weight, Matias E. Valsecchi, Takami Sato
Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 9 Year: 2010 Page: 661-665
Author(s): Fanny Julia, Luc Thomas, Charles Dumontet, Stephane Dalle
Improving the Effect of FDA-Mandated Drug Safety Alerts with Internet- Based Continuing Medical Education
Journal: Current Drug Safety
Volume: 8 Issue: 1 Year: 2013 Page: 11-16
Author(s): Carl N. Kraus, Alan T. Baldwin, R.G. McAllister
New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 461-467
Author(s): F. Ranchon,A. Boespflug,C. Rioufol,V. Schwiertz,L. Thomas,S. Dalle
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors inClinical Practice in the Volga-Ural Region of the Eurasian Continent
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 41 Year: 2023 Page: 3312-3323
Author(s): Radmir R. Rakhimov,Aleksandr V. Sultanbaev,Adel A. Izmailov,Konstantin V. Menshikov,Vadim M. Zabelin,Albert A. Izmailov,Gulshat R. Gilyazova,Svetlana M. Izmailova,Ksenia S. Bakhtiyarova,Irina R. Gilyazova,Angelina A. Izmailova
Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 6 Year: 2015 Page: 452-462
Author(s): SaÑd C. Azoury,David M. Straughan,Vivek Shukla